Concepts (202)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arteriovenous Malformations | 5 | 2025 | 50 | 2.040 |
Why?
|
| Pulmonary Veins | 5 | 2025 | 96 | 1.980 |
Why?
|
| Embolization, Therapeutic | 10 | 2025 | 279 | 1.890 |
Why?
|
| Arteriovenous Fistula | 3 | 2023 | 54 | 1.620 |
Why?
|
| Pulmonary Artery | 6 | 2025 | 341 | 1.460 |
Why?
|
| Device Removal | 7 | 2024 | 166 | 1.320 |
Why?
|
| Radiography, Interventional | 8 | 2020 | 154 | 1.250 |
Why?
|
| Catheters, Indwelling | 5 | 2024 | 113 | 1.120 |
Why?
|
| Stents | 3 | 2024 | 422 | 0.950 |
Why?
|
| Catheterization, Central Venous | 5 | 2014 | 120 | 0.950 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2024 | 43 | 0.830 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2023 | 426 | 0.790 |
Why?
|
| Vena Cava Filters | 6 | 2014 | 90 | 0.740 |
Why?
|
| Endovascular Procedures | 2 | 2024 | 334 | 0.690 |
Why?
|
| Liver Neoplasms | 5 | 2023 | 793 | 0.680 |
Why?
|
| Vena Cava, Inferior | 5 | 2014 | 143 | 0.630 |
Why?
|
| Pneumothorax | 2 | 2015 | 52 | 0.540 |
Why?
|
| Radiology, Interventional | 3 | 2021 | 66 | 0.530 |
Why?
|
| Treatment Outcome | 22 | 2025 | 9175 | 0.530 |
Why?
|
| Catheter-Related Infections | 2 | 2014 | 24 | 0.530 |
Why?
|
| Renal Dialysis | 3 | 2009 | 364 | 0.470 |
Why?
|
| Vascular Access Devices | 1 | 2014 | 6 | 0.430 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2021 | 2777 | 0.420 |
Why?
|
| Thorax | 1 | 2014 | 80 | 0.420 |
Why?
|
| Sutures | 1 | 2014 | 59 | 0.420 |
Why?
|
| Pulmonary Embolism | 4 | 2024 | 235 | 0.420 |
Why?
|
| Central Venous Catheters | 1 | 2014 | 22 | 0.410 |
Why?
|
| Gastrointestinal Hemorrhage | 3 | 2021 | 246 | 0.410 |
Why?
|
| Catheterization | 2 | 2014 | 238 | 0.400 |
Why?
|
| Suture Techniques | 1 | 2014 | 143 | 0.400 |
Why?
|
| Blood Vessel Prosthesis Implantation | 2 | 2024 | 239 | 0.390 |
Why?
|
| Bacterial Infections | 1 | 2014 | 185 | 0.390 |
Why?
|
| Computed Tomography Angiography | 3 | 2024 | 166 | 0.370 |
Why?
|
| Venous Thrombosis | 2 | 2013 | 257 | 0.350 |
Why?
|
| Chemoembolization, Therapeutic | 1 | 2011 | 32 | 0.330 |
Why?
|
| Activated Protein C Resistance | 1 | 2010 | 1 | 0.320 |
Why?
|
| Protein C Deficiency | 1 | 2010 | 4 | 0.320 |
Why?
|
| Middle Aged | 21 | 2025 | 28368 | 0.320 |
Why?
|
| Humans | 38 | 2025 | 96105 | 0.320 |
Why?
|
| Laminectomy | 1 | 2010 | 65 | 0.310 |
Why?
|
| Yttrium Radioisotopes | 4 | 2023 | 48 | 0.300 |
Why?
|
| Prosthesis Failure | 2 | 2024 | 125 | 0.300 |
Why?
|
| Head and Neck Neoplasms | 1 | 2014 | 1089 | 0.260 |
Why?
|
| Arm | 1 | 2007 | 100 | 0.260 |
Why?
|
| Angioplasty, Balloon | 1 | 2007 | 98 | 0.260 |
Why?
|
| Anticoagulants | 2 | 2010 | 463 | 0.260 |
Why?
|
| Risk Factors | 7 | 2025 | 5961 | 0.260 |
Why?
|
| Pipecolic Acids | 1 | 2006 | 14 | 0.250 |
Why?
|
| Retrospective Studies | 14 | 2024 | 10287 | 0.250 |
Why?
|
| Arteriovenous Shunt, Surgical | 1 | 2007 | 76 | 0.250 |
Why?
|
| Male | 21 | 2025 | 45863 | 0.250 |
Why?
|
| Aged | 14 | 2024 | 20968 | 0.240 |
Why?
|
| Angiography | 3 | 2021 | 209 | 0.240 |
Why?
|
| Ischemia | 1 | 2007 | 256 | 0.230 |
Why?
|
| Aged, 80 and over | 8 | 2021 | 7229 | 0.220 |
Why?
|
| Foreign-Body Migration | 1 | 2024 | 34 | 0.210 |
Why?
|
| Ileal Diseases | 1 | 2004 | 25 | 0.210 |
Why?
|
| Fibrin | 1 | 2024 | 87 | 0.210 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2023 | 15 | 0.200 |
Why?
|
| Thrombosis | 1 | 2006 | 326 | 0.200 |
Why?
|
| Vascular Calcification | 1 | 2024 | 54 | 0.200 |
Why?
|
| Female | 22 | 2025 | 50028 | 0.200 |
Why?
|
| Intestinal Obstruction | 1 | 2004 | 94 | 0.200 |
Why?
|
| Hematoma | 1 | 2004 | 109 | 0.200 |
Why?
|
| Diagnosis, Differential | 2 | 2024 | 1619 | 0.200 |
Why?
|
| Cholangiocarcinoma | 1 | 2023 | 80 | 0.190 |
Why?
|
| Predictive Value of Tests | 2 | 2024 | 1805 | 0.190 |
Why?
|
| Bile Duct Neoplasms | 1 | 2023 | 91 | 0.190 |
Why?
|
| Adult | 15 | 2025 | 28721 | 0.180 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2014 | 883 | 0.180 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2024 | 248 | 0.180 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 2463 | 0.180 |
Why?
|
| Hepatic Artery | 2 | 2021 | 84 | 0.180 |
Why?
|
| Young Adult | 7 | 2025 | 7025 | 0.170 |
Why?
|
| Fistula | 1 | 2021 | 42 | 0.170 |
Why?
|
| Phlebography | 5 | 2014 | 67 | 0.170 |
Why?
|
| Vascularized Composite Allotransplantation | 1 | 2021 | 17 | 0.170 |
Why?
|
| Hospital Units | 1 | 2020 | 29 | 0.170 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 24 | 0.160 |
Why?
|
| Catheterization, Peripheral | 1 | 2021 | 64 | 0.160 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 59 | 0.160 |
Why?
|
| Radiology Information Systems | 1 | 2020 | 78 | 0.160 |
Why?
|
| Brachytherapy | 1 | 2021 | 127 | 0.160 |
Why?
|
| Time Factors | 6 | 2025 | 5580 | 0.150 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2021 | 247 | 0.140 |
Why?
|
| Social Media | 1 | 2020 | 111 | 0.140 |
Why?
|
| Adolescent | 5 | 2025 | 9895 | 0.140 |
Why?
|
| Medicare | 1 | 2021 | 458 | 0.140 |
Why?
|
| Biopsy, Needle | 2 | 2015 | 231 | 0.130 |
Why?
|
| Societies, Medical | 1 | 2020 | 644 | 0.120 |
Why?
|
| Immunosuppressive Agents | 1 | 2021 | 995 | 0.120 |
Why?
|
| Incidence | 3 | 2015 | 1715 | 0.120 |
Why?
|
| Chest Tubes | 1 | 2015 | 21 | 0.120 |
Why?
|
| Mesenteric Arteries | 1 | 2015 | 29 | 0.120 |
Why?
|
| Hemostatics | 2 | 2012 | 61 | 0.110 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2014 | 38 | 0.110 |
Why?
|
| Femoral Vein | 1 | 2014 | 42 | 0.110 |
Why?
|
| Brachiocephalic Veins | 1 | 2014 | 33 | 0.110 |
Why?
|
| Postoperative Complications | 2 | 2015 | 2591 | 0.110 |
Why?
|
| Vena Cava, Superior | 1 | 2014 | 60 | 0.100 |
Why?
|
| Jugular Veins | 1 | 2014 | 73 | 0.100 |
Why?
|
| Kidney Failure, Chronic | 2 | 2009 | 432 | 0.100 |
Why?
|
| Sex Distribution | 1 | 2014 | 175 | 0.100 |
Why?
|
| Age Distribution | 1 | 2014 | 209 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 363 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2014 | 123 | 0.100 |
Why?
|
| Equipment Design | 1 | 2014 | 427 | 0.100 |
Why?
|
| Prosthesis Implantation | 1 | 2014 | 131 | 0.100 |
Why?
|
| Illinois | 1 | 2014 | 531 | 0.090 |
Why?
|
| Endoleak | 1 | 2012 | 42 | 0.090 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 3927 | 0.090 |
Why?
|
| Prosthesis Design | 4 | 2014 | 310 | 0.090 |
Why?
|
| Biopsy | 1 | 2015 | 1220 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 1010 | 0.090 |
Why?
|
| Embolic Protection Devices | 1 | 2011 | 9 | 0.090 |
Why?
|
| Iliac Vein | 1 | 2011 | 32 | 0.080 |
Why?
|
| Sex Factors | 1 | 2014 | 1133 | 0.080 |
Why?
|
| Hernia, Hiatal | 1 | 2011 | 36 | 0.080 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2012 | 121 | 0.080 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 2011 | 43 | 0.080 |
Why?
|
| Comorbidity | 1 | 2014 | 1011 | 0.080 |
Why?
|
| Factor V | 1 | 2010 | 9 | 0.080 |
Why?
|
| Age Factors | 1 | 2014 | 1963 | 0.080 |
Why?
|
| Acrylic Resins | 1 | 2009 | 23 | 0.080 |
Why?
|
| Gelatin | 1 | 2009 | 27 | 0.080 |
Why?
|
| Castleman Disease | 1 | 2009 | 13 | 0.080 |
Why?
|
| Hepatic Duct, Common | 1 | 2009 | 10 | 0.080 |
Why?
|
| Biliary Fistula | 1 | 2009 | 11 | 0.080 |
Why?
|
| Hemoptysis | 1 | 2009 | 26 | 0.080 |
Why?
|
| Warfarin | 1 | 2010 | 107 | 0.080 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 72 | 0.070 |
Why?
|
| Periodicals as Topic | 1 | 2011 | 171 | 0.070 |
Why?
|
| Biomarkers | 1 | 2015 | 1930 | 0.070 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2011 | 210 | 0.070 |
Why?
|
| Venous Thromboembolism | 1 | 2011 | 171 | 0.070 |
Why?
|
| Bariatric Surgery | 1 | 2011 | 207 | 0.070 |
Why?
|
| Obesity, Morbid | 1 | 2011 | 247 | 0.070 |
Why?
|
| Axillary Vein | 1 | 2007 | 5 | 0.070 |
Why?
|
| Lung | 1 | 2014 | 1384 | 0.070 |
Why?
|
| Brachial Artery | 1 | 2007 | 36 | 0.070 |
Why?
|
| Chicago | 3 | 2021 | 1506 | 0.070 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 898 | 0.070 |
Why?
|
| Hemofiltration | 1 | 2006 | 11 | 0.060 |
Why?
|
| Arginine | 1 | 2006 | 144 | 0.060 |
Why?
|
| Infusions, Intravenous | 1 | 2006 | 423 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2025 | 2480 | 0.060 |
Why?
|
| Radiography | 1 | 2007 | 826 | 0.060 |
Why?
|
| Proof of Concept Study | 1 | 2024 | 57 | 0.050 |
Why?
|
| Sulfonamides | 1 | 2006 | 337 | 0.050 |
Why?
|
| Pulmonary Circulation | 1 | 2024 | 92 | 0.050 |
Why?
|
| Enema | 1 | 2004 | 39 | 0.050 |
Why?
|
| Barium Sulfate | 1 | 2004 | 41 | 0.050 |
Why?
|
| Thrombolytic Therapy | 1 | 2006 | 261 | 0.050 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2024 | 100 | 0.050 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2023 | 68 | 0.050 |
Why?
|
| Microspheres | 1 | 2023 | 105 | 0.050 |
Why?
|
| Necrosis | 1 | 2023 | 210 | 0.050 |
Why?
|
| Liver Transplantation | 1 | 2009 | 1201 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2004 | 744 | 0.040 |
Why?
|
| Retreatment | 1 | 2021 | 106 | 0.040 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 55 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2020 | 138 | 0.040 |
Why?
|
| Workflow | 1 | 2020 | 80 | 0.040 |
Why?
|
| Workload | 1 | 2020 | 133 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2020 | 125 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 2039 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 830 | 0.040 |
Why?
|
| Contrast Media | 1 | 2004 | 1096 | 0.040 |
Why?
|
| United States | 2 | 2021 | 7768 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 2880 | 0.030 |
Why?
|
| Infant | 1 | 2004 | 3363 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2021 | 1791 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2015 | 171 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 219 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2013 | 76 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 4671 | 0.020 |
Why?
|
| Manometry | 1 | 2011 | 45 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 1985 | 0.020 |
Why?
|
| Contraindications | 1 | 2011 | 70 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2011 | 509 | 0.020 |
Why?
|
| Gastroesophageal Reflux | 1 | 2011 | 121 | 0.020 |
Why?
|
| Portal System | 1 | 2009 | 13 | 0.020 |
Why?
|
| Observer Variation | 1 | 2011 | 626 | 0.020 |
Why?
|
| Balloon Occlusion | 1 | 2009 | 33 | 0.020 |
Why?
|
| Liver Failure | 1 | 2009 | 69 | 0.020 |
Why?
|
| Ultrasonography, Interventional | 1 | 2009 | 125 | 0.020 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2009 | 111 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 819 | 0.020 |
Why?
|
| Anastomosis, Surgical | 1 | 2009 | 283 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2011 | 306 | 0.020 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2011 | 292 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2009 | 276 | 0.020 |
Why?
|
| Liver Diseases | 1 | 2009 | 249 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2011 | 815 | 0.020 |
Why?
|
| Thrombectomy | 1 | 2009 | 220 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 1349 | 0.020 |
Why?
|
| Mice | 1 | 2021 | 12537 | 0.020 |
Why?
|
| Graft Survival | 1 | 2009 | 942 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 1979 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 3110 | 0.010 |
Why?
|
| Asthma | 1 | 2011 | 1051 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 28891 | 0.010 |
Why?
|